Cargando…
Oral treatment with etoposide in small cell lung cancer – dilemmas and solutions
BACKGROUND: Etoposide is a chemotherapeutic agent, widely used for the treatment of various malignancies, including small cell lung cancer (SCLC), an aggressive disease with poor prognosis. Oral etoposide administration exhibits advantages for the quality of life of the patient as well as economic b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573828/ https://www.ncbi.nlm.nih.gov/pubmed/23450046 http://dx.doi.org/10.2478/raon-2013-0008 |